Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. - Fautrel, B; Guillemin, F; Meyer, O (Arthritis Rheum, 2009)
et al.